Sector: —

Revolution Medicines is a clinical-stage oncology company developing targeted therapies against RAS and related cancer-driving mutations.

4 tracked filer(s) hold this · 3 opened, 0 added, 0 trimmed in 31-MAR-2026

Aggregate 13FScore 56 — mean of 4 scored holder(s) · buyers (new/add) avg 56. Higher = the smart money in this name has the better track record.

Filer	13FScore	This quarter	Shares	Value	% of their book
Darwin Global Management, Ltd. (auto-surfaced)	34	New buy	2,211,018	$204,983,479	5.4%
Stanley Druckenmiller / Duquesne	91	New buy	315,860	$30,717	0.9%
Ancora	42	New buy	268	$26,063	0.0%
Louis Bacon / Moore	56	Holds (flat)	55,600	$5,407,100	0.1%

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-07-20.

REVOLUTION MEDICINES INC